Rucaparib or Physician's Choice in Metastatic Prostate Cancer. Fizazi K, Piulats JM, Reaume MN, Ostler P, et al. N Engl J Med 2023 Feb 16. doi: 10.1056/NEJMoa2214676.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fizazi K, Piulats JM, Reaume MN, Ostler P, et al. Rucaparib or Physician's Choice in Metastatic Prostate Cancer. N Engl J Med 2023 Feb 16. doi: 10.1056/NEJMoa2214676.
PMID: 36795891